Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03752216
What this trial is testing

NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 141
Early research (Phase 1)Study completedNCT02643498
What this trial is testing

A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 11
Large-scale testing (Phase 3)Looking for participantsNCT03651206
What this trial is testing

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Who this might be right for
Ovarian CarcinosarcomaEndometrial Carcinosarcoma
ARCAGY/ GINECO GROUP 138
Large-scale testing (Phase 3)Study completedNCT02603432
What this trial is testing

Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

Who this might be right for
Urothelial Cancer
Pfizer 700
Not applicableStudy completedNCT02913014
What this trial is testing

Comparison of Recurrence of Atrial Fibrillation Post Cryoballon Ablation During the 90-day Blanking Period-with and Without Anti-arrhythmic Drug Therapy

Who this might be right for
Atrial Fibrillation
Prisma Health-Midlands 50
Testing effectiveness (Phase 2)Study completedNCT01719549
What this trial is testing

Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1

Who this might be right for
Gastric Cancer
Asan Medical Center 19
Not applicableNot Yet RecruitingNCT07644455
What this trial is testing

Percutaneous Biopsy After Neoadjuvant Chemotherapy.

Who this might be right for
Breast Cancer
Instituto do Cancer do Estado de São Paulo 100
Not applicableUnknownNCT03789851
What this trial is testing

Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 50
Large-scale testing (Phase 3)Ended earlyNCT01662102
What this trial is testing

Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)

Who this might be right for
Follicular Lymphoma
Spectrum Pharmaceuticals, Inc 1
Testing effectiveness (Phase 2)Study completedNCT07824505
What this trial is testing

Lucitanib (AL3810) in Patients With Advanced Thymic Carcinoma After Chemotherapy

Who this might be right for
Advanced Thymic Carcinoma
Haihe Biopharma Co., Ltd. 74
Large-scale testing (Phase 3)Looking for participantsNCT06609551
What this trial is testing

CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study

Who this might be right for
Colon CancerColon Cancer (Stage II &Amp;Amp;Amp; III)
Zhejiang Cancer Hospital 312
Not applicableStudy completedNCT05274594
What this trial is testing

Efficacy of Preoperative Radiotherapy for Non-responder Patients After Neoadjuvant Chemotherapy

Who this might be right for
Breast NeoplasmsRadiotherapy; ComplicationsSurvivorship+1 more
Istanbul Breast Society 37
Testing effectiveness (Phase 2)WithdrawnNCT02580253
What this trial is testing

Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University
Testing effectiveness (Phase 2)Study completedNCT02047201
What this trial is testing

Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Lithuanian University of Health Sciences 40
Very early researchLooking for participantsNCT06220214
What this trial is testing

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast CancerNeoadjuvant Chemotherapy+3 more
Alison Stopeck 30
Not applicableStudy completedNCT05125614
What this trial is testing

Gastric Cancer Survival Without Chemotherapy

Who this might be right for
Gastric Cancer
Saint Vincent's Hospital, Korea 342
Large-scale testing (Phase 3)Looking for participantsNCT04261244
What this trial is testing

NeoRad Breast Cancer Study

Who this might be right for
Breast Cancer
Bielefeld University 1,826
Large-scale testing (Phase 3)Study completedNCT00363584
What this trial is testing

Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University Hospital Southampton NHS Foundation Trust 360
Not applicableUnknownNCT04986306
What this trial is testing

The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients

Who this might be right for
Breast CancerSentinel Lymph Node BiopsyNeoadjuvant Therapy
National Cheng-Kung University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02271464
What this trial is testing

Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana 232
Next Page